The European Association of Nuclear Medicine (EANM) has announced the release of a guideline for scintigraphic evaluation of the thyroid. The guideline was published online on 7 August in the European Journal of Nuclear Medicine and Molecular Imaging.
Its purpose is to "assist imaging specialists and clinicians in recommending, performing, and interpreting the results of thyroid scintigraphy (including positron emission tomography) with various radiopharmaceuticals and radioiodine uptake test in patients with different thyroid diseases," lead author Dr. Luca Giovanella of the Oncology Institute of Southern Switzerland in Bellinzona and colleagues wrote.
In other EANM news, the association is calling for new members for its Drug Development Committee. Those interested should contact Silvia Marchetti at the EANM Executive Office at [email protected].
